A Retrospective Study for Mucosal Malignant Melanoma of the Head and Neck treated with Carbon-ion Radiotherapy Combined with DAV Chemotherapy

A Retrospective Study for Mucosal Malignant Melanoma of the Head and Neck treated with Carbon-ion Radiotherapy Combined with DAV Chemotherapy - Carbon-ion Radiotherapy Combined with DAV Chemotherapy for Mucosal Malignant Melanoma of the Head and Neck

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032199

Enrollment

100

Registered

2018-04-15

Start date

2018-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucosal Malignant Melanoma of the Head and Neck

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) histologically confirmed mucosal malignant melanoma of the head and neck, 2) N0M0, 3) inoperable tumor, 4) age between 15 and 80 years, 5) Performance status score <2, 6) grossly measurable tumor.

Exclusion criteria

Exclusion criteria: 1) prior radiotherapy to the Carbon-ion radiotherapy treated area, 2) serious medical or psychological conditions precluding the safe administration of treatment.

Design outcomes

Primary

Measure	Time frame
Local control rate	—

Secondary

Measure	Time frame
Overall survival rate	—

Countries

Japan

Contacts

Public Contactizumi Kaneko

National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Scienc Hospital

helsinki@qst.go.jp043-206-3306

Outcome results